|
Volumn 22, Issue 4, 2007, Pages 207-213
|
Can intensive statin therapy halt the progression of atherosclerosis? Recent evidence and potential implications for patient management.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ANGIOCARDIOGRAPHY;
ATHEROSCLEROSIS;
BLOOD;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CORONARY ARTERY DISEASE;
DISEASE COURSE;
DRUG EFFECT;
DRUG MONITORING;
ECHOCARDIOGRAPHY;
ENDOSCOPIC ECHOGRAPHY;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
HEART CATHETERIZATION;
HUMAN;
IMMUNOLOGY;
METHODOLOGY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT SELECTION;
PRACTICE GUIDELINE;
REVIEW;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
ATHEROSCLEROSIS;
CHOLESTEROL, LDL;
CLINICAL TRIALS AS TOPIC;
CORONARY ANGIOGRAPHY;
CORONARY DISEASE;
DISEASE PROGRESSION;
DRUG MONITORING;
ECHOCARDIOGRAPHY;
EVIDENCE-BASED MEDICINE;
FOLLOW-UP STUDIES;
HEART CATHETERIZATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MAGNETIC RESONANCE IMAGING;
PATIENT SELECTION;
PRACTICE GUIDELINES AS TOPIC;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
ULTRASONOGRAPHY, INTERVENTIONAL;
|
EID: 38949208919
PISSN: 08897204
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0889-7204.2007.06575.x Document Type: Review |
Times cited : (3)
|
References (35)
|